Organogenesis
regenerative medicine company
Based in MA
🤖
AI Overview
With $40K in lobbying spend across 28 quarterly filings, Organogenesis is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2024.
$40K
Total Spend
7
Years Active
1
Firms Hired
7
Lobbyists Deployed
2
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $0 |
| 2019 | $30K |
| 2020 | $0 |
| 2021 | $0 |
| 2022 | $10K |
| 2023 | $0 |
| 2024 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues
- •Medicare reimbursement issues
- •Issues related to Medicare reimbursement of drugs and devices.
- •Issues regarding prescription drug pricing.
- •Issues regarding Medicare Part B covered drugs and devices.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.